Recruiting A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study) NCT07292246 Conditions Adenocarcinoma, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, +19 more Locations Mediterraneo Hospital — Glyfada, Attica, Greece View Trial Details
Completed Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. NCT02000622 Conditions BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Cancer Metastatic, +10 more Locations Research Site — San Diego, California, United States Research Site — Santa Rosa, California, United States Research Site — Whittier, California, United States Research Site — Denver, Colorado, United States View all 171 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) NCT01945775 Conditions BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Diseases, +5 more Locations Arizona Oncology Associates P.C. - NAHOA — Flagstaff, Arizona, United States HonorHealth — Scottsdale, Arizona, United States Virginia G. Piper Cancer Pharmacy — Scottsdale, Arizona, United States Kaiser Permanente Medical Center Lab Drawing Station — Antioch, California, United States View all 362 locations View more locations Show fewer locations Loading locations... View Trial Details
